Rocket Lab Stock PLUMMETS 33%! Neutron Delay SHOCKER! Is RKLB Overvalued NOW?
Did you know Rocket Lab stock plummeted 33% last month, yet experts still warn it's drastically overvalued? This sharp decline was primarily triggered by the unexpected delay of its crucial Neutron rocket test flights, now pushed back to 2026. However, Rocket Lab continues to grow rapidly, boasting a $500 million backlog for its smaller Electron rockets and expanding its space systems revenue, even participating in a Mars mission. Despite this impressive growth and being up 100% over the last year, the company is burning through $232 million in cash and holds an extremely high price-to-sales ratio. Ultimately, the future hinges on the Neutron's successful launch to manage its significant cash burn. Make sure to subscribe to our channel for more deep dives into the volatile world of investing.
Tags/Hashtags: #rklb #stock #investing #spacex #overvalued #spacex
Leave a Reply